Navigation Links
Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
Date:2/27/2013

Sunnyvale, CA. (PRWEB) February 27, 2013

EO2 Concepts, a medical device company based in San Antonio, TX, endorses Clinovo for its open-source Electronic Data Capture (EDC) system: ClinCapture

EO2 Concepts chose to implement Clinovo’s open-source EDC system for a 120 patient clinical study to treat diabetic foot ulcers using oxygenation, with 10 US based sites. Clinovo deployed the clinical database according to timelines, meeting the customer’s needs and expectations.

EO2 Concepts was really impressed by the ease-of-use of ClinCapture. “I was amazed to see how easy the new release of ClinCapture was to use. I already thought ClinCapture was a great open-source Electronic Data Capture (EDC) system, but this new release is absolutely fantastic” explains Mark Niederauer, Ph.D., Chief Technology Officer at EO2 Concepts.

To start your free trial of ClinCapture visit this page.

EO2 Concepts was looking for a cost-efficient, 21 CFR part 11 compliant Electronic Data Capture (EDC) system. They needed a flexible eClinical system that could be easily re-used for their upcoming studies. The medical device company also wanted to keep control of their data, which ClinCapture offers as an open-source EDC solution.

EO2 Concepts selected Clinovo amongst several vendors for two main reasons: The cost/benefit comparison with the other EDC systems available on the market and ClinCapture’s flexibility and advanced customization. The quality of the support and training packages were the final deciding factors in their decision to contract Clinovo for their clinical trial.

Services provided included study build, hosting, training and support. EO2 Concepts was extremely satisfied with the level of customer service, and points out Clinovo’s excellent team responsiveness at all levels of the organization. They also enjoyed Clinovo’s pro-active approach of finding alternate solutions to better address their needs.

To start your free trial of ClinCapture visit this page.

About EO2 Concepts

EO2 Concepts is an advanced wound care technology company. The company develops and commercializes electrochemical low-dose tissue oxygenation and wound monitoring systems. Their flagship product, TransCu O2®, is an FDA cleared Class III medical device intended to treat difficult to heal wounds such as venous leg ulcers, diabetic foot ulcers and pressure ulcers.

About ClinCapture

ClinCapture is an advanced, flexible open-source electronic data capture (EDC) platform designed to streamline clinical trials. As an open-source EDC solution, ClinCapture is tailored to meet the needs of life science companies looking to run cost-effective clinical trials.

About Clinovo

Clinovo partners with life science companies to streamline their clinical trials, leveraging years of expertise in systems integration, open-source technology and industry standards. Clinovo provides Staffing Solutions, eClinical Systems and Biometrics Services including Clinical Data Management, Electronic Data Capture, CDISC mapping, SAS Programming and technical trainings.

Contact information
Sophie McCallum, Marketing Manager
sophie.mccallum(at)clinovo(dot)com
415-990-4838

Read the full story at http://www.prweb.com/releases/2013/2/prweb10471855.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Drogueria Americana, a Honduran Affiliate of GeneCell International, Presents to a Panel of More Than 100 Leading Dentist on Dental Pulp Stem Cells
2. Biotrial, a Leading Provider of Drug Development Services, Has Completed its Acquisition of Warnex Bioanalytical Services Division
3. Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
4. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
5. ViaCytes Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012
6. Agency Take-up Soars of Agnitios Leading Pull Marketing Platform for the Healthcare Industry
7. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
8. The Leading Edge Of Medical Innovation: New Prenatal Genetic Tests Use Moms Blood To Learn About Her Baby
9. Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
10. Speech and Language Therapy Jobs and Biomedical Science Jobs - Medicspro Leading the way for Medical Recruitment Agencies in the UK
11. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... studies (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or ... Salivary Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 ... company, and Beyond Type 1, a not-for-profit advocacy and ... today announced a grant from Beyond Type 1 to ... type 1 and other insulin-requiring diabetes.  ... innovative stem cell-derived cell replacement therapies with a focus ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):